參考文獻 |
(1) P. Georgel et al., "Virus-host interactions in hepatitis C virus infection: implications
for molecular pathogenesis and antiviral strategies", Trends in molecular medicine, 16,
277, 2010
(2) P. D. Nagy, J. Pogany, "The dependence of viral RNA replication on co-opted host
factors", Nature reviews. Microbiology, 10, 137, 2012
(3) T. L. Tellinghuisen, C. M. Rice, "Interaction between hepatitis C virus proteins and
host cell factors", Current opinion in microbiology, 5, 419, 2002
(4) C. Giannini, C. Brechot, "Hepatitis C virus biology", Cell death and differentiation, 10
Suppl 1, S27, 2003
(5) P. Pileri et al., "Binding of hepatitis C virus to CD81", Science, 282, 938, 1998
(6) M. J. Evans et al., "Claudin-1 is a hepatitis C virus co-receptor required for a late step
in entry", Nature, 446, 801, 2007
(7) S. Hopkins et al., "The cyclophilin inhibitor SCY-635 suppresses viral replication and
induces endogenous interferons in patients with chronic HCV genotype 1 infection",
Journal of hepatology, 2012
(8) A. Albecka et al., "Role of low-density lipoprotein receptor in the hepatitis C virus life
cycle", Hepatology, 55, 998, 2012
(9) A. J. Lyons, J. R. Lytle, J. Gomez, H. D. Robertson, "Hepatitis C virus internal
59
ribosome entry site RNA contains a tertiary structural element in a functional domain
of stem-loop II", Nucleic acids research, 29, 2535, 2001
(10) M. Yanagi, M. St Claire, S. U. Emerson, R. H. Purcell, J. Bukh, "In vivo analysis of
the 3’’ untranslated region of the hepatitis C virus after in vitro mutagenesis of an
infectious cDNA clone", Proceedings of the National Academy of Sciences of the
United States of America, 96, 2291, 1999
(11) C. S. Fraser, J. A. Doudna, "Structural and mechanistic insights into hepatitis C viral
translation initiation", Nature reviews. Microbiology, 5, 29, 2007
(12) J. A. Hiscox, "The interaction of animal cytoplasmic RNA viruses with the nucleus to
facilitate replication", Virus research, 95, 13, 2003
(13) Y. Liu, E. Wimmer, A. V. Paul, "Cis-acting RNA elements in human and animal
plus-strand RNA viruses", Biochimica et biophysica acta, 1789, 495, 2009
(14) E. Martinez-Salas, A. Pacheco, P. Serrano, N. Fernandez, "New insights into internal
ribosome entry site elements relevant for viral gene expression", The Journal of
general virology, 89, 611, 2008
(15) G. A. Otto, J. D. Puglisi, "The pathway of HCV IRES-mediated translation initiation",
Cell, 119, 369, 2004
(16) C. M. Spahn et al., "Hepatitis C virus IRES RNA-induced changes in the
conformation of the 40s ribosomal subunit", Science, 291, 1959, 2001
60
(17) M. Zuker, "Mfold web server for nucleic acid folding and hybridization prediction",
Nucleic acids research, 31, 3406, 2003
(18) D. Moradpour, F. Penin, C. M. Rice, "Replication of hepatitis C virus", Nature reviews.
Microbiology, 5, 453, 2007
(19) R. K. Jangra, M. Yi, S. M. Lemon, "Regulation of hepatitis C virus translation and
infectious virus production by the microRNA miR-122", Journal of virology, 84, 6615,
2010
(20) J. I. Henke et al., "microRNA-122 stimulates translation of hepatitis C virus RNA",
The EMBO journal, 27, 3300, 2008
(21) W. C. Tsai et al., "MicroRNA-122, a tumor suppressor microRNA that regulates
intrahepatic metastasis of hepatocellular carcinoma", Hepatology, 49, 1571, 2009
(22) R. K. Jangra, M. Yi, S. M. Lemon, "Regulation of hepatitis C virus translation and
infectious virus production by the microRNA miR-122", J Virol, 84, 6615,
(23) T. Shimakami et al., "Stabilization of hepatitis C virus RNA by an Ago2-miR-122
complex", Proceedings of the National Academy of Sciences of the United States of
America, 109, 941, 2012
(24) C. S. Chen et al., "A proteome chip approach reveals new DNA damage recognition
activities in Escherichia coli", Nat Methods, 5, 69, 2008
(25) C. S. Chen et al., "Identification of novel serological biomarkers for inflammatory
61
bowel disease using Escherichia coli proteome chip", Mol Cell Proteomics, 8, 1765,
2009
(26) H. Zhu et al., "Global analysis of protein activities using proteome chips", Science,
293, 2101, 2001
(27) H. Zhu, M. Bilgin, M. Snyder, "Proteomics", Annu Rev Biochem, 72, 783, 2003
(28) J. Zhu et al., "RNA-binding proteins that inhibit RNA virus infection", Proceedings of
the National Academy of Sciences of the United States of America, 104, 3129, 2007
(29) Y. Y. Lin et al., "Protein acetylation microarray reveals that NuA4 controls key
metabolic target regulating gluconeogenesis", Cell, 136, 1073, 2009
(30) S. C. Tao, C. S. Chen, H. Zhu, "Applications of protein microarray technology", Comb
Chem High Throughput Screen, 10, 706, 2007
(31) J. Zhu et al., "Protein array identification of substrates of the Epstein-Barr virus
protein kinase BGLF4", J Virol, 83, 5219, 2009
(32) L. A. Kung et al., "Global analysis of the glycoproteome in Saccharomyces cerevisiae
reveals new roles for protein glycosylation in eukaryotes", Mol Syst Biol, 5, 308, 2009
(33) S. Hu et al., "Profiling the human protein-DNA interactome reveals ERK2 as a
transcriptional repressor of interferon signaling", Cell, 139, 610, 2009
(34) R. Li et al., "Conserved herpesvirus kinases target the DNA damage response pathway
and TIP60 histone acetyltransferase to promote virus replication", Cell host & microbe,
62
10, 390, 2011
(35) M. R. Chapman, C. C. Kao, "A minimal RNA promoter for minus-strand RNA
synthesis by the brome mosaic virus polymerase complex", J Mol Biol, 286, 709, 1999
(36) K. Sivakumaran, M. Hema, C. C. Kao, "Brome mosaic virus RNA syntheses in vitro
and in barley protoplasts", J Virol, 77, 5703, 2003
(37) K. J. Livak, T. D. Schmittgen, "Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", Methods, 25, 402,
2001
(38) A. Kozomara, S. Griffiths-Jones, "miRBase: integrating microRNA annotation and
deep-sequencing data", Nucleic acids research, 39, D152, 2011
(39) C. UniProt, "Reorganizing the protein space at the Universal Protein Resource
(UniProt)", Nucleic acids research, 40, D71, 2012
(40) T. Y. Hsieh et al., "Hepatitis C virus core protein interacts with heterogeneous nuclear
ribonucleoprotein K", The Journal of biological chemistry, 273, 17651, 1998
(41) M. Costa, J. L. Rodriguez-Sanchez, A. J. Czaja, C. Gelpi, "Isolation and
characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec
complex recognized by autoantibodies from patients withtype-1 autoimmune
hepatitis", Clinical and experimental immunology, 121, 364, 2000
(42) M. Volkmann et al., "Soluble liver antigen: isolation of a 35-kd recombinant protein
63
(SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis",
Hepatology, 33, 591, 2001
(43) I. Wies et al., "Identification of target antigen for SLA/LP autoantibodies in
autoimmune hepatitis", Lancet, 355, 1510, 2000
(44) J. Wang et al., "Hepatitis C virus non-structural protein NS5A interacts with FKBP38
and inhibits apoptosis in Huh7 hepatoma cells", FEBS letters, 580, 4392, 2006
(45) H. L. Bonkovsky et al., "Porphyria cutanea tarda, hepatitis C, and HFE gene mutations
in North America", Hepatology, 27, 1661, 1998
(46) T. Tsutsumi et al., "Interaction of hepatitis C virus core protein with retinoid X
receptor alpha modulates its transcriptional activity", Hepatology, 35, 937, 2002
(47) W. H. Huang, B. Y. Yung, W. J. Syu, Y. H. Lee, "The nucleolar phosphoprotein B23
interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA
replication", The Journal of biological chemistry, 276, 25166, 2001
(48) K. Yuksek, W. L. Chen, D. Chien, J. H. Ou, "Ubiquitin-independent degradation of
hepatitis C virus F protein", Journal of virology, 83, 612, 2009
(49) H. Aoki, J. Hayashi, M. Moriyama, Y. Arakawa, O. Hino, "Hepatitis C virus core
protein interacts with 14-3-3 protein and activates the kinase Raf-1", Journal of
virology, 74, 1736, 2000
(50) T. H. Lee, S. J. Elledge, J. S. Butel, "Hepatitis B virus X protein interacts with a
64
probable cellular DNA repair protein", Journal of virology, 69, 1107, 1995
(51) O. Leupin, S. Bontron, M. Strubin, "Hepatitis B virus X protein and simian virus 5 V
protein exhibit similar UV-DDB1 binding properties to mediate distinct activities",
Journal of virology, 77, 6274, 2003
(52) N. Lin-Marq, S. Bontron, O. Leupin, M. Strubin, "Hepatitis B virus X protein
interferes with cell viability through interaction with the p127-kDa UV-damaged
DNA-binding protein", Virology, 287, 266, 2001
(53) N. O. Ku, S. Michie, R. G. Oshima, M. B. Omary, "Chronic hepatitis, hepatocyte
fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a
keratin 18 conserved arginine mutant", The Journal of cell biology, 131, 1303, 1995
(54) J. Y. Lin et al., "Heterogeneous nuclear ribonuclear protein K interacts with the
enterovirus 71 5’’ untranslated region and participates in virus replication", The Journal
of general virology, 89, 2540, 2008
(55) M. J. Matunis, W. M. Michael, G. Dreyfuss, "Characterization and primary structure
of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein",
Molecular and cellular biology, 12, 164, 1992
(56) D. Dhar et al., "Human ribosomal protein L18a interacts with hepatitis C virus internal
ribosome entry site", Archives of virology, 151, 509, 2006
(57) Y. Inoue et al., "Ubiquitous presence of cellular proteins that specifically bind to the 3’’
65
terminal region of hepatitis C virus", Biochemical and biophysical research
communications, 245, 198, 1998
(58) G. Luo, "Cellular proteins bind to the poly(U) tract of the 3’’ untranslated region of
hepatitis C virus RNA genome", Virology, 256, 105, 1999
(59) J. Wood, R. M. Frederickson, S. Fields, A. H. Patel, "Hepatitis C virus 3’’X region
interacts with human ribosomal proteins", Journal of virology, 75, 1348, 2001
(60) S. Hu, Z. Xie, J. Qian, S. Blackshaw, H. Zhu, "Functional protein microarray
technology", Wiley interdisciplinary reviews. Systems biology and medicine, 3, 255,
2011
(61) L. Peyrin-Biroulet et al., "Interaction of ribavirin with azathioprine metabolism
potentially induces myelosuppression", Alimentary pharmacology & therapeutics, 28,
984, 2008
(62) T. Reiberger et al., "Mitochondrial toxicity is associated with virological response in
patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly
active antiretroviral therapy", The Journal of infectious diseases, 202, 156, 2010
(63) B. Horoldt et al., "Results of combination treatment with pegylated interferon and
ribavirin in cirrhotic patients with hepatitis C infection", Liver international : official
journal of the International Association for the Study of the Liver, 26, 650, 2006
(64) C. F. Huang et al., "Efficacy and safety of pegylated interferon combined with
66
ribavirin for the treatment of older patients with chronic hepatitis C", The Journal of
infectious diseases, 201, 751, 2010
(65) M. L. Vachon, D. T. Dieterich, "The era of direct-acting antivirals has begun: the
beginning of the end for HCV?", Seminars in liver disease, 31, 399, 2011
(66) C. Welsch, A. Jesudian, S. Zeuzem, I. Jacobson, "New direct-acting antiviral agents
for the treatment of hepatitis C virus infection and perspectives", Gut, 61 Suppl 1, i36,
2012
(67) G. T. Strickland, S. S. El-Kamary, P. Klenerman, A. Nicosia, "Hepatitis C vaccine:
supply and demand", The Lancet infectious diseases, 8, 379, 2008
(68) K. J. Blight, J. A. McKeating, C. M. Rice, "Highly permissive cell lines for
subgenomic and genomic hepatitis C virus RNA replication", Journal of virology, 76,
13001, 2002
|